Dietary modulation of gut microbiome and host gene expression across human evolution and the emergence of modern human disease
人类进化和现代人类疾病出现过程中肠道微生物组和宿主基因表达的饮食调节
基本信息
- 批准号:9518889
- 负责人:
- 金额:$ 92.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptionAdultAffectAfricanAgricultureAmericasC-reactive proteinCardiovascular DiseasesCivilizationDataDietDietary InterventionDiseaseDisease modelEnergy MetabolismEvolutionExpression ProfilingFecesGene ExpressionGeneticGenetic MarkersGenomeGenomicsGlucose Metabolism DisordersGlycosylated hemoglobin AGoalsHigh Density LipoproteinsHumanHuman GenomeImmuneIncidenceIndustrializationInflammationInflammatoryIntrinsic factorJamaicaLife StyleLightMachine LearningMammalsMeasuresMediatingMetabolicMetabolic DiseasesMetabolic MarkerMetabolic syndromeMetagenomicsMicrobeModelingModernizationNutrientNutritionalPatternPopulationPopulations at RiskPrimatesPublic HealthResolutionRisk FactorsRoleSamplingSocietiesStructureSystemTNF geneTNFRSF1A geneTherapeutic InterventionTissue-Specific Gene ExpressionTissuesTriglyceridesTrinidadVariantWorkbasecohortdensitydisease phenotypedisorder riskfecal metabolomeglycemic controlgut microbiomehuman diseaseimprovedlearning strategylipid metabolismmetabolomemetabolomicsmetagenomemicrobialmicrobial hostmicrobiomemicrobiome compositionmultiple omicsnovelnutrition related geneticstheoriestranscriptome sequencingtranscriptomicstranslational approach
项目摘要
Evidence suggests that lifestyle changes, concordant with the adoption of agriculture and industrialization, have
impacted the emergence of the so-called diseases of modern civilization in humans (e.g. metabolic disorders,
cardiovascular disease etc.). The incidence of these diseases in contemporary, industrialized populations is
believed to be associated with a lack of adaptation of our genomes to the rapid dietary and lifestyle changes that
occurred across human evolution. However the usefulness and resolution of this evolutionary model of disease
are limited. Moreover, although the dietary and genetic markers of human evolution have been studied, we still
lack understanding on how the microbiome, our second genome, has interacted with nutritional and host-
genomic axes to confer increased disease risk in modern humans. Preliminary data by our group show that
dietary shifts significantly modulate the gut microbiome and metabolome of wild primates, our closest
evolutionary relatives. Additionally, we have identified gut microbiome markers only found in populations
representing Paleolithic lifestyles (hunter-gatherers) and distinguishing them from traditional agriculturalists and
industrialized populations. Thus, given 1) the potential role of diet in human evolution, 2) the critical impact of
the gut microbiome on the nutritional and immune landscape of mammals, and 3) the existence of gut
microbiome patterns exclusive of hunter-gatherers, we hypothesize that the emergence of metabolic disease in
modern humans was significantly mediated by interactions between diet, the gut microbiome and the human
genome across evolution. These issues are still unexplored. Thus, in Aim 1 of this proposal we will use a multi-
OMIC approach (gut metabolomics, metagenomics and transcriptomics of the host colonic tissue) to identify
metabolic and genetic markers that emerged and/or were lost when humans transitioned from hunter-gatherer
to agricultural and industrialized lifestyles, and in humans affected by metabolic disease phenotypes. In Aim 2,
we will use integrated meta-OMICs and network theory approaches to predict metabolic disease phenotypes,
from hunter-gatherers to, populations in transition to agriculture to modern populations at risk. This system-level
study will broaden our understanding of the extrinsic (environmental/nutritional) and intrinsic factors
(genetic/metabolic) impacting the evolution of modern human disease. Additionally, the evolutionary approach
proposed will shed light on potentially novel diet and microbe-based translational strategies to mitigate the
incidence of metabolic disease in contemporary human populations.
有证据表明,生活方式的改变,与农业和工业化的采用相一致,具有
影响了所谓的现代文明疾病在人类中的出现(例如代谢紊乱,
心血管疾病等)。这些疾病在当代工业化人口中的发病率是
据信与我们的基因组缺乏适应快速的饮食和生活方式变化有关
发生在整个人类进化过程中。然而,这种疾病进化模型的有用性和解析性
是有限的。此外,尽管人类进化的饮食和遗传标记已经被研究过,但我们仍然
缺乏对微生物组,我们的第二个基因组,如何与营养和宿主相互作用的了解-
基因组轴赋予现代人更高的疾病风险。我们小组的初步数据显示,
饮食变化显著地调节了野生灵长类动物的肠道微生物群和代谢组,这是我们最接近的
进化中的亲戚。此外,我们已经确定了仅在人群中发现的肠道微生物组标记。
代表旧石器时代的生活方式(狩猎-采集者),并将他们与传统的农学家和
工业化人口。因此,鉴于1)饮食在人类进化中的潜在作用,2)饮食的关键影响
肠道微生物群对哺乳动物的营养和免疫格局的影响;3)肠道的存在
不包括狩猎-采集者的微生物组模式,我们假设代谢性疾病在
现代人在很大程度上是通过饮食、肠道微生物群和人类之间的相互作用来调节的
整个进化过程的基因组。这些问题仍未得到探索。因此,在本提案的目标1中,我们将使用多个
组学方法(肠道代谢组学、宿主结肠组织的元基因组学和转录组学)来鉴定
当人类从狩猎-采集过渡时出现和/或丢失的代谢和遗传标记
农业和工业化的生活方式,以及受代谢性疾病表型影响的人类。在目标2中,
我们将使用集成的荟萃组学和网络理论方法来预测代谢性疾病的表型,
从狩猎-采集者到向农业转型的人口到处于危险之中的现代人口。这个系统级别
研究将扩大我们对外在(环境/营养)和内在因素的理解
(遗传/新陈代谢)影响现代人类疾病的进化。此外,进化论方法
建议将阐明潜在的新的饮食和基于微生物的翻译策略,以缓解
代谢性疾病在当代人类人群中的发病率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Harinder Singh其他文献
Harinder Singh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Harinder Singh', 18)}}的其他基金
Dietary modulation of gut microbiome and host gene expression across human evolution and the emergence of modern human disease
人类进化和现代人类疾病出现过程中肠道微生物组和宿主基因表达的饮食调节
- 批准号:
9892997 - 财政年份:2017
- 资助金额:
$ 92.04万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 92.04万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 92.04万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 92.04万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 92.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 92.04万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 92.04万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 92.04万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 92.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 92.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 92.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)